Biotechnology News and Research

RSS

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.

1 Nov 2023

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the unique aspects of Phenaros' drug discovery platform, and the synergy between academia and industry.

From ELRIG (UK) Ltd. 1 Nov 2023

New project combines traditional methods with metaviromics to study viral outbreaks in wild rodents

When, where, and why do diseases jump from animals to people? A new project will monitor how changing seasons, land use, and human behavior influence viral outbreaks in wild rodent populations, to identify hotspots with high potential for spillover into people.

31 Oct 2023

New AI tool could lead to precision medicine by predicting drug response

An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult.

31 Oct 2023

AI may help identify potential gonorrhea vaccine proteins

Gonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics.

31 Oct 2023

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.

30 Oct 2023

Imperial researchers discover hidden mechanism behind feeling touch

Imperial researchers have discovered a hidden mechanism within hair follicles that allow us to feel touch.

27 Oct 2023

New bioreactor could accelerate access to cancer-killing immunotherapy

A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body's immune response to target cancer cells.

26 Oct 2023

Sphere Fluidics' Expansion and Vision

In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics' new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.

From Sphere Fluidics 25 Oct 2023

What's really in your kombucha and kefir?

Researchers have delved into the bacterial diversity of 47 different fermented foods, revealing significant variations in microbial richness and composition. The study highlights that foods like kombucha and kefirs have high microbial diversity, while plant-based yogurt alternatives and fermented vegetables show lower levels.

24 Oct 2023

AI tool effectively detects distress in hospital workers' conversations

An artificial intelligence tool effectively detected distress in hospital workers' conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.

24 Oct 2023

Plant microorganisms from fruit and vegetables boost gut diversity

Bacterial diversity in the gut plays an important role in human health. The crucial question, however, is where are the sources of this diversity? It is known that an important part of the maternal microbiome is transferred to the baby at birth, and the same happens during the breastfeeding period via breast milk.

24 Oct 2023

Global surge of highly pathogenic avian influenza H5N1

A recent study published in Nature sheds light on the complex dynamics of highly pathogenic avian influenza (HPAI) H5N1 since 2021, uncovering critical shifts in the virus's behavior and providing insights for more effective mitigation strategies. The research emphasizes the importance of understanding the ecological and virological factors driving the intensified global activity of HPAI H5N1 to better prepare for and manage future outbreaks.

22 Oct 2023

New method uses magnets to align muscle cells

Stimulating muscle fibers with magnets causes them to grow in the same direction, aligning muscle cells within tissue, Massachusetts Institute of Technology (MIT) and Boston University investigators report October 20 in the journal Device.

20 Oct 2023

New method to study gut microbiome opens door to new medical opportunities

The more diverse species in your gut, the better it is for your health. Now an international team led by the Hudson Institute of Medical Research has found a way to determine which species are important and how they interact to create a healthy microbiome.

20 Oct 2023

Experts from the research and innovation community invited to tackle anti-microbial resistance

Researchers, policy-makers and business leaders from across the research and innovation community are invited to help tackle one of humanity’s biggest threats, anti-microbial resistance (AMR).

20 Oct 2023

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine ("Insilico") has been invited to present scientific data on its novel anti-cancer assets at three major upcoming cancer conferences -- the European Society for Medical Oncology (ESMO) conference in Madrid Oct. 20-24, 2023; the Society of Immunotherapy of Cancer (SITC) conference Nov. 1-5, 2023 in San Diego; and the San Antonio Breast Cancer Symposium (SABCS) Dec. 5-9, 2023.

16 Oct 2023

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse Ltd (Antiverse) and GlobalBio, Inc. (GlobalBio) today announced they will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy.

From Antiverse 16 Oct 2023

£800,000 grant to boost the development of bacteriophages to combat disease

Pioneering work to develop effective and safe bacteriophages to combat disease has received an £800,000 boost.

13 Oct 2023

Nongenetic mechanisms play a role in lung cancer treatment resistance

In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and other institutions found that nongenetic mechanisms are important in lung cancer patients who develop a resistance to one cancer therapy.

13 Oct 2023